APA (7th ed.) Citation

Zhou, G., Xing, R., Wang, Z., Li, R., Liu, S., Li, H., & Li, G. (2026). Chitosan and chito-oligosaccharides as multifunctional therapeutics for metabolic dysfunction-associated steatotic liver disease (MASLD). Carbohydrate polymers.

Chicago Style (17th ed.) Citation

Zhou, Gaoli, Ronge Xing, Zongji Wang, Rongfeng Li, Song Liu, Hang Li, and Guantian Li. Chitosan and Chito-oligosaccharides as Multifunctional Therapeutics for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD). Carbohydrate polymers, 2026.

MLA (9th ed.) Citation

Zhou, Gaoli, et al. Chitosan and Chito-oligosaccharides as Multifunctional Therapeutics for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD). Carbohydrate polymers, 2026.